Surrozen (SRZN)

• Market cap: $204M
• 1 day: 3.28%
• 5 days: 18.56%
• 1 month: 90.03%
• 3 months: 112.53%
• 6 months: 161.6%
• Year to date: 72.56%
• 1 year: 153.24%
• 5 years: -83.79%
• 10 years: -83.79%
• Sector: Healthcare
• Industry: Biotechnology

About: Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Employees: 41